Allergy Therapeutics plc (AGY.L)
GBp 7.0
(2.94%)
GBp 7.0
(2.94%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -35.25 Million GBP | N/A |
| 2022 | -34.85 Million GBP | -168.06% |
| 2021 | -13 Million GBP | -591.9% |
| 2020 | 2.64 Million GBP | -40.71% |
| 2019 | 4.45 Million GBP | 342.81% |
| 2018 | -1.83 Million GBP | 72.61% |
| 2017 | -6.7 Million GBP | -238.41% |
| 2016 | -1.98 Million GBP | 83.66% |
| 2015 | -12.12 Million GBP | -1740.32% |
| 2014 | 739 Thousand GBP | -26.32% |
| 2013 | 1 Million GBP | 50.15% |
| 2012 | 668 Thousand GBP | -38.83% |
| 2011 | 1.09 Million GBP | 849.57% |
| 2010 | 115 Thousand GBP | -92.1% |
| 2009 | 1.45 Million GBP | -71.47% |
| 2008 | 5.1 Million GBP | -67.27% |
| 2007 | 15.59 Million GBP | -40.65% |
| 2006 | 26.27 Million GBP | 291.35% |
| 2005 | 6.71 Million GBP | 177.67% |
| 2004 | 2.41 Million GBP | 55.4% |
| 2003 | 1.55 Million GBP | 199.3% |
| 2002 | -1.56 Million GBP | -136.86% |
| 2001 | 4.25 Million GBP | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q2 | -11.88 Million GBP | 0.0% |
| 2022 FY | -34.85 Million GBP | -168.06% |
| 2022 Q4 | -27.94 Million GBP | 0.0% |
| 2022 Q2 | -7.81 Million GBP | 0.0% |
| 2021 Q2 | 7.16 Million GBP | 0.0% |
| 2021 FY | -13 Million GBP | -591.9% |
| 2021 Q4 | -20.15 Million GBP | 0.0% |
| 2020 Q4 | -8.83 Million GBP | 0.0% |
| 2020 FY | 2.64 Million GBP | -40.71% |
| 2020 Q2 | 12.29 Million GBP | 0.0% |
| 2019 FY | 4.45 Million GBP | 342.81% |
| 2019 Q4 | -8.27 Million GBP | 0.0% |
| 2019 Q2 | 12.79 Million GBP | 0.0% |
| 2018 Q2 | 10.73 Million GBP | 0.0% |
| 2018 Q4 | -6.91 Million GBP | 0.0% |
| 2018 FY | -1.83 Million GBP | 72.61% |
| 2017 Q2 | 6.42 Million GBP | 0.0% |
| 2017 FY | -6.7 Million GBP | -238.41% |
| 2017 Q4 | -13.12 Million GBP | 0.0% |
| 2016 Q2 | 7.23 Million GBP | 0.0% |
| 2016 FY | -1.98 Million GBP | 83.66% |
| 2016 Q4 | -9.21 Million GBP | 0.0% |
| 2015 Q4 | -13.49 Million GBP | 0.0% |
| 2015 Q2 | 1.37 Million GBP | 0.0% |
| 2015 FY | -12.12 Million GBP | -1740.32% |
| 2014 FY | 739 Thousand GBP | -26.32% |
| 2014 Q2 | 7.52 Million GBP | 0.0% |
| 2014 Q4 | -6.78 Million GBP | 0.0% |
| 2013 FY | 1 Million GBP | 50.15% |
| 2013 Q4 | -5.64 Million GBP | 0.0% |
| 2013 Q2 | 6.65 Million GBP | 0.0% |
| 2012 Q2 | 5.27 Million GBP | 0.0% |
| 2012 FY | 668 Thousand GBP | -38.83% |
| 2012 Q4 | -4.79 Million GBP | -2971.86% |
| 2012 Q3 | 167 Thousand GBP | -96.84% |
| 2011 Q4 | 273 Thousand GBP | 0.0% |
| 2011 Q3 | 273 Thousand GBP | 0.0% |
| 2011 FY | 1.09 Million GBP | 849.57% |
| 2011 Q1 | 529.25 Thousand GBP | 0.0% |
| 2011 Q2 | 273 Thousand GBP | -48.42% |
| 2010 Q1 | 576.5 Thousand GBP | 0.0% |
| 2010 FY | 115 Thousand GBP | -92.1% |
| 2010 Q4 | 529.25 Thousand GBP | 0.0% |
| 2010 Q3 | 529.25 Thousand GBP | 0.0% |
| 2010 Q2 | 529.25 Thousand GBP | -8.2% |
| 2009 FY | 1.45 Million GBP | -71.47% |
| 2009 Q2 | 576.5 Thousand GBP | 250.72% |
| 2009 Q3 | 576.5 Thousand GBP | 0.0% |
| 2009 Q4 | 576.5 Thousand GBP | 0.0% |
| 2009 Q1 | -382.5 Thousand GBP | 0.0% |
| 2008 Q2 | -382.5 Thousand GBP | 89.87% |
| 2008 Q1 | -3.77 Million GBP | 0.0% |
| 2008 Q3 | -382.5 Thousand GBP | 0.0% |
| 2008 Q4 | -382.5 Thousand GBP | 0.0% |
| 2008 FY | 5.1 Million GBP | -67.27% |
| 2007 Q4 | -3.77 Million GBP | 0.0% |
| 2007 Q1 | -6.53 Million GBP | 0.0% |
| 2007 Q2 | -3.77 Million GBP | 42.19% |
| 2007 Q3 | -3.77 Million GBP | 0.0% |
| 2007 FY | 15.59 Million GBP | -40.65% |
| 2006 Q1 | -1.59 Million GBP | 0.0% |
| 2006 Q4 | -6.53 Million GBP | 0.0% |
| 2006 Q3 | -6.53 Million GBP | 0.0% |
| 2006 Q2 | -6.53 Million GBP | -309.66% |
| 2006 FY | 26.27 Million GBP | 291.35% |
| 2005 Q1 | -449.75 Thousand GBP | 0.0% |
| 2005 Q2 | -1.59 Million GBP | -254.42% |
| 2005 Q3 | -1.59 Million GBP | 0.0% |
| 2005 Q4 | -1.59 Million GBP | 0.0% |
| 2005 FY | 6.71 Million GBP | 177.67% |
| 2004 Q3 | -449.75 Thousand GBP | 0.0% |
| 2004 Q4 | -449.75 Thousand GBP | 0.0% |
| 2004 Q1 | 389 Thousand GBP | 0.0% |
| 2004 Q2 | -449.75 Thousand GBP | -215.62% |
| 2004 FY | 2.41 Million GBP | 55.4% |
| 2003 Q4 | 389 Thousand GBP | 0.0% |
| 2003 Q1 | -391.75 Thousand GBP | 0.0% |
| 2003 FY | 1.55 Million GBP | 199.3% |
| 2003 Q2 | 389 Thousand GBP | 199.3% |
| 2003 Q3 | 389 Thousand GBP | 0.0% |
| 2002 Q2 | -391.75 Thousand GBP | 62.72% |
| 2002 FY | -1.56 Million GBP | -136.86% |
| 2002 Q4 | -391.75 Thousand GBP | 0.0% |
| 2002 Q3 | -391.75 Thousand GBP | 0.0% |
| 2002 Q1 | -1.05 Million GBP | 0.0% |
| 2001 Q2 | -1.05 Million GBP | 0.0% |
| 2001 Q3 | -1.05 Million GBP | 0.0% |
| 2001 Q4 | -1.05 Million GBP | 0.0% |
| 2001 FY | 4.25 Million GBP | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|